# Polyunsaturated fatty acids promote M2-like TAM deposition via dampening RhoA-YAP1 signaling in the ovarian cancer microenvironment

**Authors:** Huogang Wang, Mingo MH Yung, Yang Xuan, Fushun Chen, Waisun Chan, Michelle KY Siu, Runying Long, Shuo Jia, Yonghao Liang, Dakang Xu, Zhangfa Song, Stephen KW Tsui, Hextan YS Ngan, Karen KL Chan, David W Chan

PMC · DOI: 10.1186/s40164-024-00558-8 · 2024-08-28

## TL;DR

Polyunsaturated fatty acids in ovarian cancer ascites promote M2-like tumor-associated macrophages by inhibiting RhoA-YAP1 signaling, which worsens tumor progression and suggests new immunotherapy strategies.

## Contribution

The study identifies a novel mechanism by which PUFAs in the tumor microenvironment drive M2-like TAM polarization through RhoA-YAP1 signaling inhibition.

## Key findings

- PUFAs in OCM/AS suppress RhoA-GTPase activity and reduce nuclear YAP1 in macrophages, promoting M2-like TAM polarization.
- Loss of YAP1 in TAMs correlates with reduced CD8+ T cell infiltration and enhanced tumor progression in EOC.
- Pharmacological activation of YAP1 converts M2-like TAMs to M1-like, improving antitumor immunity and reducing metastasis.

## Abstract

Peritoneal metastases frequently occur in epithelial ovarian cancer (EOC), resulting in poor prognosis and survival rates. Tumor-associated-macrophages (TAMs) massively infiltrate into ascites spheroids and are multi-polarized as protumoral M2-like phenotype, orchestrating the immunosuppression and promoting tumor progression. However, the impact of omental conditioned medium/ascites (OCM/AS) on TAM polarization and its function in tumor progression remains elusive.

The distribution and polarization of TAMs in primary and omental metastatic EOC patients’ tumors and ascites were examined by m-IHC, FACS analysis, and immunofluorescence. QPCR, immunofluorescence, FACS analysis, lipid staining assay, ROS assay, and Seahorse real-time cell metabolic assay characterized TAMs as being polarized in the ascites microenvironment. The oncogenic role of TAMs in tumor cells was demonstrated by co-cultured migration/invasion, proliferation, and spheroid formation assays. Mechanistic studies of the regulations of TAM polarization were performed by using RNA-Seq, GTPase pull-down, G-LISA activation assays, and other biochemical assays. A Yap1 macrophages (MФs) conditional knockout (cKO) mouse model demonstrated the roles of YAP1 in TAM polarization status and its pro-metastatic function. Finally, the anti-metastatic potential of targeting TAMs through restoring YAP1 by pharmacological agonist XMU MP1 was demonstrated in vitro and in vivo.

Abundant polyunsaturated fatty acids (PUFAs) in OCM/AS suppressed RhoA-GTPase activities, which, in turn, downregulated nuclear YAP1 in MФs, leading to increased protumoral TAM polarization accompanied by elevated OXPHOS metabolism. Abolishment of YAP1 in MФs further confirmed that a higher M2/M1 ratio of TAM polarization could alleviate CD8+ T cell infiltration and cytotoxicity in vivo. Consistently, the loss of YAP1 has been observed in EOC metastatic tissues, suggesting its clinical relevance. On the contrary, restoration of YAP1 expression by pharmaceutical inhibition of MST1/2 induced conversion of M2-to-M1-like polarized MФs, elevating the infiltration of CD8+ T cells and attenuating tumor growth.

This study revealed that PUFAs-enriched OCM/AS of EOC promotes M2-like TAM polarization through RhoA-YAP1 inhibition, where YAP1 downregulation is required for accelerating protumoral M2-like TAM polarization, thereby causing immunosuppression and enhancing tumor progression. Conversion of M2-to-M1-like polarized MФs through Yap1 activation inhibits tumor progression and contributes to developing potential TAMs-targeted immunotherapies in combating EOC peritoneal metastases.

The online version contains supplementary material available at 10.1186/s40164-024-00558-8.

## Linked entities

- **Genes:** RHOA (ras homolog family member A) [NCBI Gene 387], YAP1 (Yes1 associated transcriptional regulator) [NCBI Gene 10413], MST1 (macrophage stimulating 1) [NCBI Gene 4485], STK3 (serine/threonine kinase 3) [NCBI Gene 6788]
- **Chemicals:** XMU MP1 (PubChem CID 121499143)
- **Diseases:** ovarian cancer (MONDO:0005140), epithelial ovarian cancer (MONDO:0005140)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Yap1 (yes-associated protein 1) [NCBI Gene 22601] {aka Yap, Yap65, Yki, Yorkie}, RHOA (ras homolog family member A) [NCBI Gene 387] {aka ARH12, ARHA, EDFAOB, RHO12, RHOH12}, CD8A (CD8 subunit alpha) [NCBI Gene 925] {aka CD8, CD8alpha, IMD116, Leu2, p32}, YAP1 (Yes1 associated transcriptional regulator) [NCBI Gene 10413] {aka COB1, YAP, YAP-1, YAP2, YAP65, YKI}
- **Diseases:** Tumor- (MESH:D009369), ascites (MESH:D001201), ovarian cancer (MESH:D010051), Peritoneal metastases (MESH:D010538), cytotoxicity (MESH:D064420), EOC (MESH:D000077216)
- **Species:** Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]
- **Cell lines:** OCM — Homo sapiens (Human), Amelanotic melanoma, Cancer cell line (CVCL_6935)

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11360340/full.md

---
Source: https://tomesphere.com/paper/PMC11360340